These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 17692575

  • 1. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
    Nafee N, Taetz S, Schneider M, Schaefer UF, Lehr CM.
    Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
    [Abstract] [Full Text] [Related]

  • 2. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP, Quan DP, Liao KR, Tao Wang, Peng Xiang, Mai KC.
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [Abstract] [Full Text] [Related]

  • 3. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P, Xu Y, Zeng C, Ren H, Peng M.
    Int J Pharm; 2011 Aug 30; 415(1-2):259-66. PubMed ID: 21645597
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI, Kim JC, Kim YH, Tae G, Lee SY, Kim K, Kwon IC.
    J Control Release; 2010 May 10; 143(3):374-82. PubMed ID: 20109508
    [Abstract] [Full Text] [Related]

  • 6. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X, Zou W, Liu C, Zhang N, Fu C.
    Drug Dev Ind Pharm; 2009 Nov 10; 35(11):1375-83. PubMed ID: 19832638
    [Abstract] [Full Text] [Related]

  • 7. The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.
    Taetz S, Nafee N, Beisner J, Piotrowska K, Baldes C, Mürdter TE, Huwer H, Schneider M, Schaefer UF, Klotz U, Lehr CM.
    Eur J Pharm Biopharm; 2009 Jun 10; 72(2):358-69. PubMed ID: 18703137
    [Abstract] [Full Text] [Related]

  • 8. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F, Hosseini-Nasr M, Rad-Malekshahi M, Samadi N, Atyabi F, Dinarvand R.
    Nanomedicine; 2007 Jun 10; 3(2):161-7. PubMed ID: 17468055
    [Abstract] [Full Text] [Related]

  • 9. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
    Kim BS, Kim CS, Lee KM.
    Arch Pharm Res; 2008 Aug 10; 31(8):1050-4. PubMed ID: 18787796
    [Abstract] [Full Text] [Related]

  • 10. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
    Win KY, Feng SS.
    Biomaterials; 2005 May 10; 26(15):2713-22. PubMed ID: 15585275
    [Abstract] [Full Text] [Related]

  • 11. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M, Sapin A, Arıca-Yegin B, Merlin JL, Becuwe P, Maincent P.
    Int J Pharm; 2011 Jan 17; 403(1-2):276-84. PubMed ID: 21044878
    [Abstract] [Full Text] [Related]

  • 12. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
    Nie H, Wang CH.
    J Control Release; 2007 Jul 16; 120(1-2):111-21. PubMed ID: 17512077
    [Abstract] [Full Text] [Related]

  • 13. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.
    Tahara K, Furukawa S, Yamamoto H, Kawashima Y.
    Int J Pharm; 2010 Jun 15; 392(1-2):311-3. PubMed ID: 20347023
    [Abstract] [Full Text] [Related]

  • 14. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.
    Nanomedicine; 2007 Dec 15; 3(4):246-57. PubMed ID: 18068091
    [Abstract] [Full Text] [Related]

  • 15. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency.
    Gvili K, Benny O, Danino D, Machluf M.
    Biopolymers; 2007 Dec 15; 85(5-6):379-91. PubMed ID: 17266128
    [Abstract] [Full Text] [Related]

  • 16. Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2'-O-methyl-RNA.
    Dong M, Philippi C, Loretz B, Nafee N, Schaefer UF, Friedel G, Ammon-Treiber S, Griese EU, Lehr CM, Klotz U, Mürdter TE.
    Int J Pharm; 2011 Oct 31; 419(1-2):33-42. PubMed ID: 21782910
    [Abstract] [Full Text] [Related]

  • 17. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
    Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y.
    Int J Pharm; 2009 Dec 01; 382(1-2):198-204. PubMed ID: 19646519
    [Abstract] [Full Text] [Related]

  • 18. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
    Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin QR, Kim DD, Chung SJ, Shim CK.
    Int J Pharm; 2009 Apr 17; 371(1-2):142-7. PubMed ID: 19118614
    [Abstract] [Full Text] [Related]

  • 19. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW, Wang SS, Tsai WJ.
    Biomaterials; 2008 Jan 17; 29(2):228-37. PubMed ID: 17953984
    [Abstract] [Full Text] [Related]

  • 20. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
    Wang ZH, Wang ZY, Sun CS, Wang CY, Jiang TY, Wang SL.
    Biomaterials; 2010 Feb 17; 31(5):908-15. PubMed ID: 19853292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.